ES2375436T8 - Administración intranasal o por inhalación de virosomas. - Google Patents

Administración intranasal o por inhalación de virosomas. Download PDF

Info

Publication number
ES2375436T8
ES2375436T8 ES09178084T ES09178084T ES2375436T8 ES 2375436 T8 ES2375436 T8 ES 2375436T8 ES 09178084 T ES09178084 T ES 09178084T ES 09178084 T ES09178084 T ES 09178084T ES 2375436 T8 ES2375436 T8 ES 2375436T8
Authority
ES
Spain
Prior art keywords
virosomas
inhalation
intranasal administration
intranasal
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09178084T
Other languages
English (en)
Other versions
ES2375436T3 (es
Inventor
Alexander J. Kersten
Lisya Gerez
Pieter J. Schoen
Jozef J.P Nauta
Dorine Van Rheineck Leyssius
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Biologicals BV
Original Assignee
Abbott Biologicals BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Biologicals BV filed Critical Abbott Biologicals BV
Application granted granted Critical
Publication of ES2375436T3 publication Critical patent/ES2375436T3/es
Publication of ES2375436T8 publication Critical patent/ES2375436T8/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
ES09178084T 2006-03-22 2007-03-21 Administrador intranasal o por inhalación de virosomas. Active ES2375436T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US78446206P 2006-03-22 2006-03-22
EP06111534 2006-03-22
EP06111534 2006-03-22
US784462P 2006-03-22

Publications (2)

Publication Number Publication Date
ES2375436T3 ES2375436T3 (es) 2012-02-29
ES2375436T8 true ES2375436T8 (es) 2012-03-15

Family

ID=38038698

Family Applications (2)

Application Number Title Priority Date Filing Date
ES09178084T Active ES2375436T3 (es) 2006-03-22 2007-03-21 Administrador intranasal o por inhalación de virosomas.
ES07727166T Active ES2338382T3 (es) 2006-03-22 2007-03-21 Vacuna intranasal antigripal basada en virosomas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES07727166T Active ES2338382T3 (es) 2006-03-22 2007-03-21 Vacuna intranasal antigripal basada en virosomas.

Country Status (21)

Country Link
EP (2) EP2158921B1 (es)
JP (1) JP5285595B2 (es)
KR (1) KR20090016659A (es)
AR (1) AR059972A1 (es)
AT (2) ATE451931T1 (es)
AU (1) AU2007228736B2 (es)
BR (1) BRPI0709864A2 (es)
CA (1) CA2646895A1 (es)
DE (1) DE602007003815D1 (es)
DK (2) DK2158921T3 (es)
EA (1) EA014532B1 (es)
ES (2) ES2375436T3 (es)
HR (2) HRP20100144T1 (es)
IL (1) IL193840A (es)
MY (1) MY142996A (es)
NO (1) NO20084452L (es)
PL (2) PL1996229T3 (es)
PT (2) PT2158921E (es)
SA (1) SA07280116B1 (es)
SI (2) SI1996229T1 (es)
WO (1) WO2007107585A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110150926A1 (en) * 2008-08-01 2011-06-23 Mohammed Alsharifi Influenza vaccines
KR20130140050A (ko) * 2010-11-02 2013-12-23 헥토 마뉴엘 제페다 로페즈 Ａ/ｈ1ｎ1 범유행 인플루엔자 바이러스에 대한 신규한 백신
US11523988B2 (en) 2018-11-29 2022-12-13 Catalent U.K. Swindon Zydis Limited Oral dispersible vaccine comprising virosomes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9018690D0 (en) * 1990-08-24 1990-10-10 Wellcome Found Vaccines
EP1447080A1 (en) * 2003-02-13 2004-08-18 Bestewil Holding B.V. Method for producing virosome-like particles
TWI329130B (en) * 2003-06-19 2010-08-21 Bestewil Holding Bv Functionally reconstituted viral membranes containing adjuvant

Also Published As

Publication number Publication date
EP2158921A1 (en) 2010-03-03
DK1996229T3 (da) 2010-05-03
WO2007107585A1 (en) 2007-09-27
SI1996229T1 (sl) 2010-04-30
PL2158921T3 (pl) 2012-06-29
CA2646895A1 (en) 2007-09-27
PT2158921E (pt) 2012-03-27
DK2158921T3 (da) 2012-05-07
PT1996229E (pt) 2010-03-16
ES2338382T3 (es) 2010-05-06
ATE451931T1 (de) 2010-01-15
SI2158921T1 (sl) 2012-03-30
AR059972A1 (es) 2008-05-14
JP5285595B2 (ja) 2013-09-11
EP2158921B1 (en) 2012-01-04
SA07280116B1 (ar) 2010-10-19
NO20084452L (no) 2008-10-22
IL193840A0 (en) 2011-08-01
BRPI0709864A2 (pt) 2011-07-26
EP1996229A1 (en) 2008-12-03
EP1996229B1 (en) 2009-12-16
JP2009530351A (ja) 2009-08-27
HRP20100144T1 (hr) 2010-04-30
ES2375436T3 (es) 2012-02-29
AU2007228736A1 (en) 2007-09-27
EA200870361A1 (ru) 2009-02-27
DE602007003815D1 (en) 2010-01-28
EA014532B1 (ru) 2010-12-30
IL193840A (en) 2011-10-31
MY142996A (en) 2011-02-14
AU2007228736B2 (en) 2011-12-15
KR20090016659A (ko) 2009-02-17
ATE539766T1 (de) 2012-01-15
HRP20120013T1 (hr) 2012-01-31
PL1996229T3 (pl) 2010-05-31

Similar Documents

Publication Publication Date Title
ATE469664T1 (de) Vernebler
CL2007002783S1 (es) Inhalador multidosis.
BRPI0920428A2 (pt) inalador.
FR2896407B3 (fr) Ambulateur
FR2909857B1 (fr) Endovalve.
BRPI0814736A2 (pt) inalador.
DE602007013051D1 (de) Sprühvorrichtung
DK2033675T3 (da) Inhalationsapparat
DE602007013317D1 (de) Inhalator
BRPI0920390A2 (pt) inalador ativado por respiração
BRPI0814248A2 (pt) Inalador
BRPI0814814A2 (pt) Inalador
ES2375436T8 (es) Administración intranasal o por inhalación de virosomas.
FR2900834B1 (fr) Jeu telepherique monorail
DE502006005852D1 (de) Anleger
NO20065998L (no) Loftemekanisme
DE202006015300U8 (de) Einteilige Knothilfe
CN300748666S (zh) 吸入器
DOS2006000054S (es) Inhalador
UA15200S (uk) Інгалятор
CL2008000714S1 (es) Inhalador.
ITCA20060010A1 (it) Spiedatore per anguille o capitoni.
ES1061978Y (es) Humificador de cigarros puros.
UA14268S (uk) Респіратор
UA12964S (uk) Респіратор